Cargando…

Heparanase from triple-negative breast cancer and platelets acts as an enhancer of metastasis

Triple-negative breast cancer (TNBC), which is characterized by inherently aggressive behavior and lack of recognized molecular targets for therapy, poses a serious threat to women's health worldwide. However, targeted treatments have yet to be made available. A crosstalk between tumor cells an...

Descripción completa

Detalles Bibliográficos
Autores principales:	Yang, Wen-Jing, Zhang, Gan-Lin, Cao, Ke-Xin, Liu, Xiao-Ni, Wang, Xiao-Min, Yu, Ming-Wei, Li, Jin-Ping, Yang, Guo-Wang
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	D.A. Spandidos 2020
Materias:	Articles
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7473754/ https://www.ncbi.nlm.nih.gov/pubmed/32945393 http://dx.doi.org/10.3892/ijo.2020.5115

Ejemplares similares

Gubenyiliu II Inhibits Breast Tumor Growth and Metastasis Associated with Decreased Heparanase Expression and Phosphorylation of ERK and AKT Pathways
por: Zhang, Yi, et al.
Publicado: (2017)

Elemene inhibits the migration and invasion of 4T1 murine breast cancer cells via heparanase
por: Zhang, Yi, et al.
Publicado: (2017)

Heparanase expression upregulates platelet adhesion activity and thrombogenicity
por: Cui, Hao, et al.
Publicado: (2016)

Helicobacter pylori promotes invasion and metastasis of gastric cancer by enhancing heparanase expression
por: Liu, Li-Ping, et al.
Publicado: (2018)

Helicobacter pylori promotes invasion and metastasis of gastric cancer by enhancing heparanase expression
por: Liu, Li-Ping, et al.
Publicado: (2021)

Salmonella alters heparanase expression and reduces tumor metastasis
por: Chiu, Huan-Min, et al.
Publicado: (2021)

GABARAPL1 acts as a potential marker and promotes tumor proliferation and metastasis in triple negative breast cancer
por: Ran, Li, et al.
Publicado: (2017)

Heparanase is a novel biomarker for immune infiltration and prognosis in breast cancer
por: Yang, Wen-Jing, et al.
Publicado: (2021)

Newly Generated Heparanase Knock-Out Mice Unravel Co-Regulation of Heparanase and Matrix Metalloproteinases
por: Zcharia, Eyal, et al.
Publicado: (2009)

MicroRNA-1258: An invasion and metastasis regulator that targets heparanase in gastric cancer
por: Shi, Jinxin, et al.
Publicado: (2021)

Syntelin inhibits triple-negative breast cancer cell proliferation and metastasis
por: Mullen, McKay, et al.
Publicado: (2021)

Role of heparanase in pulmonary hypertension
por: Wang, Lin-Jun, et al.
Publicado: (2023)

Non-enzymatic heparanase enhances gastric tumor proliferation via TFEB-dependent autophagy
por: Yang, Min, et al.
Publicado: (2022)

Mechanism-based heparanase inhibitors reduce cancer metastasis in vivo
por: de Boer, Casper, et al.
Publicado: (2022)

Correction: Non-enzymatic heparanase enhances gastric tumor proliferation via TFEB-dependent autophagy
por: Yang, Min, et al.
Publicado: (2023)

Tumour Necrosis Factor-α Gene Polymorphism Is Associated with Metastasis in Patients with Triple Negative Breast Cancer
por: Li, Hui-Hui, et al.
Publicado: (2015)

Implications of Heparanase on Heparin Synthesis and Metabolism in Mast Cells
por: Maccarana, Marco, et al.
Publicado: (2022)

Expressions of heparanase and upstream stimulatory factor in hepatocellular carcinoma
por: Chen, Bin, et al.
Publicado: (2014)

Heparanase induces necroptosis of microvascular endothelial cells to promote the metastasis of hepatocellular carcinoma
por: Chen, Xiaopeng, et al.
Publicado: (2021)

Enhanced mitochondrial fission suppresses signaling and metastasis in triple-negative breast cancer
por: Humphries, Brock A., et al.
Publicado: (2020)

ASMT Regulates Tumor Metastasis Through the Circadian Clock System in Triple-Negative Breast Cancer
por: Xie, FenFen, et al.
Publicado: (2020)

Immunotherapy for Triple-Negative Breast Cancer
por: Cao, Yifeng, et al.
Publicado: (2021)

PDL1 And LDHA act as ceRNAs in triple negative breast cancer by regulating miR-34a
por: Huang, Xiaojia, et al.
Publicado: (2017)

Heparanase Modulates Chromatin Accessibility
por: Li, Honglian, et al.
Publicado: (2023)

Heparanase and Autoimmune Diabetes
por: Simeonovic, Charmaine J., et al.
Publicado: (2013)

Heparanase and the hallmarks of cancer
por: Jayatilleke, Krishnath M., et al.
Publicado: (2020)

Cancer-Associated Fibroblasts Correlate with Tumor-Associated Macrophages Infiltration and Lymphatic Metastasis in Triple Negative Breast Cancer Patients
por: Zhou, Jing, et al.
Publicado: (2018)

Dissecting the heterogeneity of the alternative polyadenylation profiles in triple-negative breast cancers
por: Wang, Lei, et al.
Publicado: (2020)

Vaspin accelerates the proliferation, invasion and metastasis of Triple‐Negative breast cancer through MiR‐33a‐5p/ABHD2
por: Cao, Xin‐Hui, et al.
Publicado: (2022)

Impact of histotypes on preferential organ‐specific metastasis in triple‐negative breast cancer
por: Li, Yaming, et al.
Publicado: (2019)

Vitamin C Inhibits Triple-Negative Breast Cancer Metastasis by Affecting the Expression of YAP1 and Synaptopodin 2
por: Gan, Liping, et al.
Publicado: (2019)

Correlation between heparanase gene polymorphism and susceptibility to endometrial cancer
por: Cao, Hanyu, et al.
Publicado: (2020)

Accelerated Resolution of AA Amyloid in Heparanase Knockout Mice Is Associated with Matrix Metalloproteases
por: Wang, Bo, et al.
Publicado: (2012)

Fascin‐1 as a novel diagnostic marker of triple‐negative breast cancer
por: Wang, Chao‐Qun, et al.
Publicado: (2016)

New Heparanase-Inhibiting Triazolo-Thiadiazoles Attenuate Primary Tumor Growth and Metastasis
por: Barash, Uri, et al.
Publicado: (2021)

Doxorubicin-Loaded Platelet Decoys for Enhanced Chemoimmunotherapy Against Triple-Negative Breast Cancer in Mice Model
por: Dong, Hang, et al.
Publicado: (2023)

Lectin RCA-I specifically binds to metastasis-associated cell surface glycans in triple-negative breast cancer
por: Zhou, Shu-Min, et al.
Publicado: (2015)

Copper-based metal–organic framework impedes triple-negative breast cancer metastasis via local estrogen deprivation and platelets blockade
por: Wang, Sijie, et al.
Publicado: (2022)

Fabrication of Ginsenoside-Based Nanodrugs for Enhanced Antitumor Efficacy on Triple-Negative Breast Cancer
por: Zuo, Shuting, et al.
Publicado: (2022)

Lentiviral miR30-based RNA Interference against Heparanase Suppresses Melanoma Metastasis with Lower Liver and Lung Toxicity
por: Liu, Xiao-yan, et al.
Publicado: (2013)

Cannot write session to /tmp/vufind_sessions/sess_4jft1v6qoqf5prlehv5pth6i4k